Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of human coagulation factor IX in Chinese children with hemophilia B
ChiCTR2200059494Phase 4Not yet recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- May 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of human coagulation factor IX in hemophilia B (HB), sponsored by Beijing Children's Hospital. Primary endpoint: Pharmacokinetics of human coagulation factor IX. Planned start May 2022; status: not yet recruiting.
02
Drugs
human coagulation factor IX
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on ChiCTR2200059494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059494.